Product Description
Indication:Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. CombinesSGLT2 inhibitorDPP-4 inhibitorSitagliptin) for dual glucose-lowering action. Not for type 1 diabetes or diabetic ketoacidosis.
CompositionEmpagliflozin 10 mg + Sitagliptin 100 mg